Darin Lippoldt

CIK: 0001504783

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)9 (25.7%)

Position reduction

Option Exercises (M)14 (40.0%)

Derivative conversions

Awards (A)4 (11.4%)

Compensation grants

Other (G, F, J, C, D, …)8 (22.9%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

NBIX

NEUROCRINE BIOSCIENCES INC

Officer

Discretionary Trading P&L

Holdings

Transaction History (35 total)

NBIX
NEUROCRINE BIOSCIENCES INC
Sep 11, 2026
Tax Payment(F)
Direct
2.4K shares at avg. $156.22$378K
NBIX
NEUROCRINE BIOSCIENCES INC
Sep 11, 2026
Award(A)
Direct
4.5K shares-
NBIX
NEUROCRINE BIOSCIENCES INC
Jul 9, 2026
Exercise(M)
Direct
10K shares at avg. $81.49$815K
NBIX
NEUROCRINE BIOSCIENCES INC
Jul 9, 2026
Sale(S)
Direct
10K shares at avg. $179.60$1.8M
NBIX
NEUROCRINE BIOSCIENCES INC
Jun 29, 2026
Sale(S)
Direct
8.1K shares at avg. $170.03$1.4M
NBIX
NEUROCRINE BIOSCIENCES INC
Jun 29, 2026
Sale(S)
Direct
1.7K shares at avg. $170.81$289K
NBIX
NEUROCRINE BIOSCIENCES INC
Jun 29, 2026
Exercise(M)
Direct
1.7K shares at avg. $81.49$138K
NBIX
NEUROCRINE BIOSCIENCES INC
Jun 29, 2026
Exercise(M)
Direct
8.1K shares at avg. $81.49$661K
NBIX
NEUROCRINE BIOSCIENCES INC
Jun 26, 2026
Sale(S)
Direct
200 shares at avg. $169.56$34K
NBIX
NEUROCRINE BIOSCIENCES INC
Jun 26, 2026
Exercise(M)
Direct
200 shares at avg. $81.49$16K
NBIX
NEUROCRINE BIOSCIENCES INC
Feb 13, 2026
Gift(G)
Direct
365 shares-
NBIX
NEUROCRINE BIOSCIENCES INC
Feb 13, 2026
Exercise(M)
Direct
2.1K shares-
NBIX
NEUROCRINE BIOSCIENCES INC
Feb 13, 2026
Tax Payment(F)
Direct
1.1K shares at avg. $124.12$140K
NBIX
NEUROCRINE BIOSCIENCES INC
Feb 13, 2026
Award(A)
Direct
10K shares-
NBIX
NEUROCRINE BIOSCIENCES INC
Feb 13, 2026
Tax Payment(F)
Direct
5.4K shares at avg. $124.12$668K
NBIX
NEUROCRINE BIOSCIENCES INC
Feb 13, 2026
Exercise(M)
Direct
2K shares-
NBIX
NEUROCRINE BIOSCIENCES INC
Feb 13, 2026
Tax Payment(F)
Direct
1.1K shares at avg. $124.12$135K
NBIX
NEUROCRINE BIOSCIENCES INC
Feb 12, 2026
Exercise(M)
Direct
1.8K shares-
NBIX
NEUROCRINE BIOSCIENCES INC
Feb 12, 2026
Tax Payment(F)
Direct
967 shares at avg. $123.10$119K
NBIX
NEUROCRINE BIOSCIENCES INC
Jan 31, 2026
Tax Payment(F)
Direct
1.3K shares at avg. $136.06$182K
NBIX
NEUROCRINE BIOSCIENCES INC
Jan 31, 2026
Exercise(M)
Direct
2.4K shares-
NBIX
NEUROCRINE BIOSCIENCES INC
Jan 8, 2026
Exercise(M)
Direct
3.3K shares at avg. $35.99$121K
NBIX
NEUROCRINE BIOSCIENCES INC
Dec 8, 2025
Exercise(M)
Direct
4.4K shares at avg. $43.24$189K
NBIX
NEUROCRINE BIOSCIENCES INC
Dec 8, 2025
Sale(S)
Direct
4.4K shares at avg. $159.65$699K
NBIX
NEUROCRINE BIOSCIENCES INC
Feb 13, 2025
Sale(S)
Direct
1.1K shares at avg. $116.75$127K

		Type	Shares	Price		Ownership
Sep 11, 2026	NBIX NEUROCRINE BIOSCIENCES INC	Tax Payment(F)	2,419	$156.22	$377,896	Direct
Sep 11, 2026	NBIX NEUROCRINE BIOSCIENCES INC	Award(A)	4,483	-	$0	Direct
Jul 9, 2026	NBIX NEUROCRINE BIOSCIENCES INC	Exercise(M)	10,000	$81.49	$814,900	Direct
Jul 9, 2026	NBIX NEUROCRINE BIOSCIENCES INC	Sale(S)	10,000	$179.60	$1,796,014	Direct
Jun 29, 2026	NBIX NEUROCRINE BIOSCIENCES INC	Sale(S)	8,110	$170.03	$1,378,903	Direct
Jun 29, 2026	NBIX NEUROCRINE BIOSCIENCES INC	Sale(S)	1,690	$170.81	$288,676	Direct
Jun 29, 2026	NBIX NEUROCRINE BIOSCIENCES INC	Exercise(M)	1,690	$81.49	$137,718	Direct
Jun 29, 2026	NBIX NEUROCRINE BIOSCIENCES INC	Exercise(M)	8,110	$81.49	$660,884	Direct
Jun 26, 2026	NBIX NEUROCRINE BIOSCIENCES INC	Sale(S)	200	$169.56	$33,913	Direct
Jun 26, 2026	NBIX NEUROCRINE BIOSCIENCES INC	Exercise(M)	200	$81.49	$16,298	Direct
Feb 13, 2026	NBIX NEUROCRINE BIOSCIENCES INC	Gift(G)	365	-	$0	Direct
Feb 13, 2026	NBIX NEUROCRINE BIOSCIENCES INC	Exercise(M)	2,083	-	$0	Direct
Feb 13, 2026	NBIX NEUROCRINE BIOSCIENCES INC	Tax Payment(F)	1,124	$124.12	$139,511	Direct
Feb 13, 2026	NBIX NEUROCRINE BIOSCIENCES INC	Award(A)	9,968	-	$0	Direct
Feb 13, 2026	NBIX NEUROCRINE BIOSCIENCES INC	Tax Payment(F)	5,378	$124.12	$667,517	Direct
Feb 13, 2026	NBIX NEUROCRINE BIOSCIENCES INC	Exercise(M)	2,017	-	$0	Direct
Feb 13, 2026	NBIX NEUROCRINE BIOSCIENCES INC	Tax Payment(F)	1,089	$124.12	$135,167	Direct
Feb 12, 2026	NBIX NEUROCRINE BIOSCIENCES INC	Exercise(M)	1,792	-	$0	Direct
Feb 12, 2026	NBIX NEUROCRINE BIOSCIENCES INC	Tax Payment(F)	967	$123.10	$119,038	Direct
Jan 31, 2026	NBIX NEUROCRINE BIOSCIENCES INC	Tax Payment(F)	1,335	$136.06	$181,640	Direct
Jan 31, 2026	NBIX NEUROCRINE BIOSCIENCES INC	Exercise(M)	2,373	-	$0	Direct
Jan 8, 2026	NBIX NEUROCRINE BIOSCIENCES INC	Exercise(M)	3,349	$35.99	$120,531	Direct
Dec 8, 2025	NBIX NEUROCRINE BIOSCIENCES INC	Exercise(M)	4,376	$43.24	$189,218	Direct
Dec 8, 2025	NBIX NEUROCRINE BIOSCIENCES INC	Sale(S)	4,376	$159.65	$698,615	Direct
Feb 13, 2025	NBIX NEUROCRINE BIOSCIENCES INC	Sale(S)	1,086	$116.75	$126,790	Direct

1-25 of 35 transactions

About Lippoldt Darin

Lippoldt Darin (SEC CIK 0001504783) files insider reports with the SEC as Chief Legal Officer of NEUROCRINE BIOSCIENCES INC (NBIX).

Signal8 holds 10 ownership filings by Lippoldt Darin, all Form 4s, filed between Feb 4, 2025 and Sep 15, 2026. Those filings report 35 transactions, from Jan 31, 2025 to Sep 11, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Lippoldt Darin's filings is in SAN DIEGO, CA.

Recent filings by Lippoldt Darin

Sep 11, 2026: Tax withholding of NBIX shares (Form 4, code F).
Sep 11, 2026: Grant or award of NBIX shares (Form 4, code A).
Jul 9, 2026: Option exercise of NBIX shares (Form 4, code M).
Jul 9, 2026: Open-market sale of NBIX shares (Form 4, code S).
Jun 29, 2026: Open-market sales of NBIX shares (2 lines, Form 4, code S).

Other insiders filing for NEUROCRINE BIOSCIENCES INC (NBIX)

MORROW GEORGE J, Director
Gano Kyle, Chief Executive Officer
ROBERTS EIRY, Chief Medical Officer
Onyia Jude, Chief Scientific Officer
Keswani Sanjay Chandru, Chief Medical Officer
GORMAN KEVIN CHARLES, Director

How to read Form 4 transaction codes